Nov 19, 2025 3-5pm ET
Wednesday on The Robert Scott Bell Show:
Hour 1
With RFK Jr. Leading MAHA, Will Regulators Finally Act on Toxic Chemicals? Or Will ‘Hostile Politics’ Win Out? The piece presents a skeptical, investigative tone as it explores whether the appointment of Robert F. Kennedy Jr. at the helm of the Make America Healthy Again (MAHA) agenda will meaningfully shift U.S. chemical regulation or merely serve as another window dressing amid entrenched industry influence. The author recounts how well-known toxic-exposure researcher Linda Birnbaum—once head of the National Institute of Environmental Health Sciences—observes that despite decades of evidence on thousands of man-made chemicals, especially for children’s health, regulatory action remains limited. The narrative highlights that MAHA’s roadmap calls for “reforming” systems but avoid imposing true restrictions on chemical use, instead leaning toward studies and voluntary safety rather than binding limits. Further, the article emphasizes how MAHA’s ambitions already clash with what the author characterizes as “hostile politics”: industry resistance, lobbying power, and agency capture that have long slowed progress on chemical policy. The author argues that without structural overhaul—including independent science, stricter exposure standards, and shielding regulators from corporate influence—the new initiative may falter. The conclusion offers cautious hope but warns that unless the political culture shifts, the promise of MAHA will be drowned out by familiar resistance, leaving children’s health risks unaddressed.
Special Guest: Lisa Rooney
With a focus on transformative healing, Lisa Rooney blends the power of Integrative Coaching and Homeopathy to guide individuals on a journey towards reclaiming their health and vitality. Lisa is a seasoned Life Coach and Homeopathic consultant, who intimately understands the intricate dance between physical and emotional struggles, recognizing their profound impact on well-being. Specializing in guiding overwhelmed individuals, women in various life transitions, young adults, and first responders, Lisa tailors her approach to address a spectrum of challenges. Through personalized coaching sessions, Lisa helps clients navigate emotional challenges such as overwhelm, fear, trauma, and uncertainty, while also addressing physical ailments including sleep disturbances, digestive issues, chronic pain, and skin conditions.
She possesses extensive training as a Certified Professional Co-Active Coach, an Energy Healer, and a Homeopathic Consultant.
Her educational journey has taken her through esteemed institutions such as The Coaches Training Institute, Healing Touch, Energy Psychology, Lotus Health Institute, and Joette Calabrese, among others—all of which have helped her refine her integrative, multi-method approach to healing. As a mother of two young adults, she raised her children holistically, employing many of the same methods she uses today. Nestled in the greater Atlanta area with her husband and two canine companions, Lisa finds joy in traveling, kayaking, hiking, sharing movie nights with loved ones, and embracing a lifestyle in harmony with her core values.
Emotional healing from the Charlie Kirk Assassination!
Ditch and Switch!
Ditch and Switch – Reflux and Sour Stomach
Lisa Rooney has the answer!
On The Robert Scott Bell Show today, we highlight Ranunculus Sceleratus, a remedy noted in homeopathic practice for conditions involving acrid vesicles, raw sensitive skin and sharp, boring pains.
Boericke points to its usefulness when skin becomes easily irritated, when moist conditions aggravate symptoms, and when soreness or stitching discomfort appears in the chest or rib region.
Download the Information Sheet
Hour 2
What Really Happens to Your Body When You Suppress a Fever With Tylenol? The article argues in a forceful, investigative voice that Americans have been dangerously misled about Tylenol and fever suppression, insisting that the drug’s safety reputation collapses when viewed through decades of overlooked evidence. It opens by highlighting the staggering toll of acetaminophen overdose—tens of thousands of ER visits and hundreds of deaths annually—while asserting that Tylenol’s damage extends far beyond the liver, especially when used reflexively to suppress fevers. Drawing heavily from the work of “A Midwestern Doctor,” it claims Tylenol depletes glutathione, weakens detox pathways, and increases long-term risks ranging from blood cancers and hypertension to asthma, kidney injury, and developmental disorders in children of exposed pregnant women. In the author’s voice, the article frames fever suppression as a profound medical mistake: fevers activate immune cells, inhibit pathogens, trigger protective heat-shock proteins, and serve as an evolutionary defense mechanism. Suppressing them, the author argues, derails immunity and worsens outcomes, citing parallels between aspirin-related deaths during the 1918 flu and poor COVID outcomes in people who used fever reducers. Integrative medicine, Chinese medicine, and anthroposophic traditions are invoked to claim that suppression “drives disease inward,” fostering microclots, autoimmune illness, chronic inflammation, and even cancer—reinforced by historical examples such as Coley’s fever-based cancer treatments. The article extends these ideas to vaccinations, warning that giving Tylenol to infants after shots extinguishes beneficial immune reactions, deepens toxic injury, and contributes to neurological and developmental disorders. Ultimately, the piece condemns modern medicine’s obsession with suppressing symptoms, arguing that this ideology transforms short-term illnesses into lifelong chronic disease and turns healthy people into “lifelong customers.” It concludes that fevers are essential, Tylenol is far riskier than acknowledged, and ignoring these warnings has pushed society into a hidden epidemic of chronic illness that can no longer be dismissed.
Tylenol Maker Kenvue Shares Fall as US Court Weighs Reviving Autism Lawsuits The article reports in a straightforward, legal-news tone that Kenvue shares dropped after a federal appeals court signaled it may revive hundreds of lawsuits alleging the company failed to warn pregnant women about a potential link between prenatal Tylenol use and autism. During oral arguments, two judges on the three-judge Second Circuit panel openly questioned whether the lower-court judge, Denise Cote, improperly dismissed the plaintiffs’ scientific evidence and overstepped by excluding expert testimony that supported a causal connection. One judge stated directly that the district court “did some things incorrectly,” prompting immediate market reaction as Kenvue stock fell more than 2.5%. The litigation sits against a politically charged backdrop: recent warnings from President Trump, Health Secretary Robert F. Kennedy Jr., and federal health officials cautioning pregnant women against Tylenol have intensified public scrutiny, even as many experts continue to downplay the alleged link. Kenvue maintains that no credible research ties the drug to autism, defending the earlier ruling that classified plaintiffs’ expert analysis as scientifically unreliable. Plaintiffs’ counsel countered that the judge acted as an “amateur scientist,” improperly blocking a jury from weighing competing evidence. Analysts tracking the case noted that two appellate judges appeared sympathetic to the plaintiffs, suggesting a strong possibility the ruling will be overturned or remanded for reconsideration early next year. The legal stakes extend beyond Kenvue: major retailers like Walmart and CVS are also defendants, and the company—spun off from Johnson & Johnson and currently set to be acquired for $40 billion—faces renewed uncertainty as the appeals court determines whether the autism litigation will proceed.
The Preventable Plague: How Man-Made Poisons Are Fueling a Parkinson’s Epidemic The article argues with urgency that what is increasingly labeled a Parkinson’s epidemic is in fact a largely preventable public health tragedy, driven by widespread exposure to industrial pesticides (such as paraquat and rotenone), solvents (trichloroethylene and perchloroethylene) and fine-particulate air pollution (PM2.5). It posits that developed nations’ high rates of Parkinson’s—up to five times higher in industrialized regions—underscore the disease’s environmental roots, and notes that countries undergoing rapid industrialization are now seeing the fastest growth in cases. The author emphasizes that while genetic factors explain only 5 %–15 % of cases, the environmental toxicants implicated are human-made and therefore controllable. The piece critiques research funding priorities, noting that only 2 % of U.S. Parkinson’s research is devoted to prevention, while 60 % of funding is industry-sourced and focused on treatment rather than eliminating causative exposure. Detailed case evidence is offered, including military service members at Camp Lejeune exposed to solvents who later showed sharply elevated Parkinson’s risk. The article frames the standard medical approach—treating symptoms rather than identifying and removing exposures—as fundamentally flawed, calling it akin to “treating the symptoms of a poisoned population while ignoring the poison itself.” Written in a confrontational tone, it demands regulatory reform: banning the worst chemicals, cleaning up contaminated sites, and shifting research toward prevention. The conclusion issues a call to action, asserting that the means to avert millions of new cases now exists—but only if society chooses to confront the industrial roots of this disease rather than accept it as inevitable.
The Weaponisation of Science Maryanne Demasi speaks with urgency and clarity in this piece, arguing that the integrity of science has been fundamentally compromised by commercial interests, regulatory capture, and a culture of silence around dissenting findings. She explains that when researchers cannot interrogate data, question methodologies, or challenge prevailing narratives without fear of reprisal, what remains is not science but marketing masquerading as evidence. Drawing on her experience investigating the cholesterol-lowering drug industry, she tracks how legitimate scientific inquiry has been squeezed between industry funding, editorial pressure, and institutional inertia—often leading to studies being published, then quietly withdrawn or ignored when results conflict with corporate or regulatory priorities. The article highlights specific mechanisms of distortion: ghost-writing of research, use of surrogate endpoints that serve marketing goals rather than patient outcomes, and “consensus” frameworks that delegitimise minority viewpoints by framing them as misinformation. Demasi argues that this climate produces a public-health ecosystem in which risk is shifted from regulated entities (which pay lip-service to “following the science”) onto individuals—while the science itself becomes a tool of control rather than exploration. She writes with a critical voice, insisting that real reform requires more than new guidelines or policies—it demands a cultural break: transparency about funding, robust challenge to methodological orthodoxy, and protections for researchers willing to swim against the tide. In closing, she issues a call: unless truth is once again valued above profit, the weaponisation of science will deepen, and society will increasingly live under the guise of knowledge while abiding by its distortions.
Clean Air Regulations May Have Accelerated Ocean Warming The article reports that recent scientific research suggests improved air-quality regulations, while beneficial for human health, may have inadvertently reduced aerosol pollution in the atmosphere and thus diminished the cooling effect those particles had via brightening cloud cover—particularly over the Northeast Pacific and North Atlantic oceans. According to a study published in Nature Communications, from 2003 to 2022 clouds in these regions became nearly 3% less reflective per decade, with about 70% of that change attributed to the decline in aerosols that seed cloud droplets. Researchers found that fewer small particles mean larger droplets, faster precipitation, shorter-lived clouds and reduced albedo (sunlight reflection), resulting in more solar radiation being absorbed by ocean surfaces. The article points out that this mechanism helps explain why ocean and surface warming have outpaced many predictions, even as major air-pollution controls succeed. Importantly, the article emphasizes that this finding does not mean air-quality improvements are regrettable—rather, they underscore the complex feedbacks in Earth’s climate system that can offset or amplify warming in surprising ways. The piece notes that climate models will need to incorporate these aerosol-cloud interactions more accurately to forecast future warming and guide mitigation or adaptation strategies. It concludes by highlighting the policy challenge: how to maintain human-health gains from cleaner air while adjusting climate-policy frameworks to account for the newly exposed “clean-air paradox.”
Question of The Day!
Unfortunately, I don’t get to listen (or watch) all your shows and the ones I do listen to are usually several days after they are posted. I recently finished listening to the Nov. 9th show, live from the CHD conference in Austin. My name was announced as a winner of the drawing for goldbacks!! Am I still eligible to receive them? If so, I’m extremely grateful and excited – this was so unexpected!!
Jenni
Remember Friends, The Power to Heal is Yours!
